Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Income Statement [Abstract]
Net Sales	$ 7,683.9	$ 5,997.8	$ 4,673.3
Cost of products sold, excluding intangible asset amortization	2,381.8	1,800.6	1,242.8
Intangible asset amortization	565.9	337.4	92.5
Research and development	365.6	268.8	187.4
Selling, general and administrative	2,932.9	2,284.2	1,750.7
Certain claims (Note 20)		7.7	21.5
Special items (Note 2)	611.8	831.8	341.1
Operating expenses	6,858.0	5,530.5	3,636.0
Operating Profit	825.9	467.3	1,037.3
Other expense, net	(71.3)	(36.9)	(46.7)
Interest income	2.9	9.4	11.9
Interest expense	(357.9)	(286.6)	(63.1)
Earnings before income taxes	399.6	153.2	939.4
Provision for income taxes	95.0	7.0	220.2
Net earnings	304.6	146.2	719.2
Less: Net loss attributable to noncontrolling interest	(1.3)	(0.8)	(1.1)
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 305.9	$ 147.0	$ 720.3
Earnings Per Common Share - Basic	$ 1.53	$ 0.78	$ 4.26
Earnings Per Common Share - Diluted	$ 1.51	$ 0.77	$ 4.20
Weighted Average Common Shares Outstanding
Basic	200.0	187.4	169.0
Diluted	202.4	189.8	171.7
Cash Dividends Declared Per Common Share	$ 0.96	$ 0.88	$ 0.88